Alcidion to present at Investor Briefings 5-7 September 18
Filed with ASX · · 18 pages · English
CEO Ms. Kate Quirke and Executive Chairman Mr. Ray Blight will present on behalf of Alcidion. Updating the group on the latest developments within the company as a listed company. A copy of the presentation in included as an Appendix to this announcement. ENDS Kyahn Williamson WE Buchan Ph: 0401018828 [email protected] About Alcidion Alcidion Group Limited (ASX:ALC) has a simple purpose: t
Earlier from Alcidion
- Appendix 4E and FY18 Annual Report to shareholders
- Alcidion Appendix 4C - Quarterly
- Alcidion signs 3 year contract extension with NT Health
- Alcidion signs $4.75m ACT Health contract
- Alcidion completes acquisition of MKM/Patientrack
Later from Alcidion
- Alcidion FY18 Unaudited Pro Forma Results
- Alcidion signs major contract with Queensland Health
- Alcidion-2 year extension of support services to ACT Health
- Alcidion Announces Board and Management Changes
- Alcidion FY19 Half Year Report and Appendix 4D
Follow Alcidion into a list and get an email when it puts out news.
Follow Alcidion